Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Treatments With Antihistamines and Amantadine in the Evolution of the SARS-CoV-2 Infection

NCT05504057 is registered in ClinicalTrials.gov with Consorci Sanitari de Terrassa as lead sponsor.

NCT NCT05504057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05504057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Treatments With Antihistamines and Amantadine in the Evolution of the SARS-CoV-2 Infection
Lead sponsor
Consorci Sanitari de Terrassa
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2020
Completion date
February 24, 2028
Enrollment
140,660 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19